EBS - Emergent BioSolutions' (EBS) CEO Bob Kramer on Q1 2019 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS)
Q1 2019 Earnings Conference Call
May 2, 2019 5:00 PM ET
Company Participants
Bob Burrows – Vice President-Investor Relations
Bob Kramer – President and Chief Executive Officer
Rich Lindahl – Chief Financial Officer
Abbey Jenkins – Senior Vice President, Vaccines and Anti-infectives Business Unit Head
Doug Whit – Senior Vice President, Devices Business Unit Head
Conference Call Participants
Brandon Folkes – Cantor Fitzgerald
Jessica Fye – JP Morgan
Keay Nakae – Chardan
Boris Peaker – Cowen
Chris Sakai – Singular Research
Francois Brisebois – Laidlaw
Presentation
Operator
Good day, ladies and